Thus, GaTN, GaM, or the combination of nevirapine and rifampin nanoparticles resulted in significant inhibition of the growth of HIV and M. tuberculosis and decreased many cytokine production levels even when infection of the MDMs occurred 15 days after drug loading, consistent with sustained drug release from the nanoparticles. Here, GLS is linked to infection.